These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19881121)

  • 1. Etiopathogenesis of benign prostatic hypeprlasia.
    Tang J; Yang J
    Indian J Urol; 2009 Jul; 25(3):312-7. PubMed ID: 19881121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign prostatic hyperplasia: age-related tissue-remodeling.
    Untergasser G; Madersbacher S; Berger P
    Exp Gerontol; 2005 Mar; 40(3):121-8. PubMed ID: 15763388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and experimental studies of benign prostatic hyperplasia.
    Coffey DS; Walsh PC
    Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiology and disease process of benign prostatic hyperplasia.
    Isaacs JT; Coffey DS
    Prostate Suppl; 1989; 2():33-50. PubMed ID: 2482772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.
    Boudon C; Rodier G; Lechevallier E; Mottet N; Barenton B; Sultan C
    J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia.
    Schulze H; Barrack ER
    Prostate; 1987; 11(2):145-62. PubMed ID: 2444954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.
    Lin VK; Wang D; Lee IL; Vasquez D; Fagelson JE; McConnell JD
    Prostate; 2000 Aug; 44(3):193-203. PubMed ID: 10906735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic characterization of hereditary benign prostatic hyperplasia.
    Doehring CB; Sanda MG; Partin AW; Sauvageot J; Juo H; Beaty TH; Epstein JI; Hill G; Walsh PC
    Urology; 1996 Oct; 48(4):650-3. PubMed ID: 8886078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etiopathogenesis of benign prostatic hypertrophy].
    Montanari E; Guarneri A; Dell'Orto P; Gelosa M
    Arch Ital Urol Androl; 1995 Feb; 67(1):7-12. PubMed ID: 7538393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
    Giri D; Ittmann M
    Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia.
    Nassis L; Frauman AG; Ohishi M; Zhuo J; Casley DJ; Johnston CI; Fabiani ME
    J Pathol; 2001 Dec; 195(5):571-9. PubMed ID: 11745693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential impact of paired patient-derived BPH and normal adjacent stromal cells on benign prostatic epithelial cell growth in 3D culture.
    Chen W; Pascal LE; Wang K; Dhir R; Sims AM; Campbell R; Gasper G; DeFranco DB; Yoshimura N; Wang Z
    Prostate; 2020 Oct; 80(14):1177-1187. PubMed ID: 32659026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia.
    Shapiro E; Becich MJ; Hartanto V; Lepor H
    J Urol; 1992 May; 147(5):1293-7. PubMed ID: 1373778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine prostate models in preclinical studies of minimally invasive interventions: part II, benign prostatic hyperplasia models.
    Sun F; Báez-Díaz C; Sánchez-Margallo FM
    Transl Androl Urol; 2017 Jun; 6(3):547-555. PubMed ID: 28725598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia.
    Giri D; Ittmann M
    Am J Pathol; 2000 Jul; 157(1):249-55. PubMed ID: 10880394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.
    Barclay WW; Woodruff RD; Hall MC; Cramer SD
    Endocrinology; 2005 Jan; 146(1):13-8. PubMed ID: 15471963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia.
    Taoka R; Kakehi Y
    Asian J Urol; 2017 Jul; 4(3):158-163. PubMed ID: 29264225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.
    Wu Q; Zhou Y; Chen L; Shi J; Wang CY; Miao L; Klocker H; Park I; Lee C; Zhang J
    J Endocrinol; 2007 Oct; 195(1):89-94. PubMed ID: 17911400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.
    Li F; Pascal LE; Stolz DB; Wang K; Zhou Y; Chen W; Xu Y; Chen Y; Dhir R; Parwani AV; Nelson JB; DeFranco DB; Yoshimura N; Balasubramani GK; Gingrich JR; Maranchie JK; Jacobs BL; Davies BJ; Hrebinko RL; Bigley JD; McBride D; Guo P; He D; Wang Z
    Prostate; 2019 Aug; 79(11):1226-1237. PubMed ID: 31212363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.